Blood platelet disease
MONDO:0002245Disorders caused by abnormalities in platelet count or function.
Also known as: platelet abnormality, platelet disorder, thrombocytopathy
370 clinical trials for this condition and its sub-types, 18 tagged with Blood platelet disease itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Part of
Sub-types of Blood platelet disease
-
Thrombocytopenia 75 trials · 267 incl. sub-types
6 sub-types
- Thrombocytopenic purpura 8 trials · 116 incl. sub-types Sub-types →
- Autoimmune thrombocytopenia 8 trials · 113 incl. sub-types Sub-types →
- Thrombocytopenia due to immune destruction 81 trials
- Inherited thrombocytopenia 2 trials · 29 incl. sub-types Sub-types →
- Acquired thrombocytopenia 11 trials · 24 incl. sub-types Sub-types →
- Neonatal thrombocytopenia 5 trials Sub-types →
-
Thrombocytosis disease 7 trials · 71 incl. sub-types
3 sub-types
- Essential thrombocythemia 67 trials
- Familial thrombocytosis 2 trials Sub-types →
- Reactive thrombocytosis 0 trials
-
Inherited bleeding disorder, platelet-type 6 trials · 26 incl. sub-types
28 sub-types
- Glanzmann thrombasthenia 8 trials Sub-types →
- Platelet-type bleeding disorder 10 8 trials
- Congenital thrombotic thrombocytopenic purpura 5 trials
- Macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss 1 trial
- Bernard-Soulier syndrome 0 trials Sub-types →
- Ehlers-Danlos syndrome, fibronectinemic type 0 trials
- Quebec platelet disorder 0 trials
- Scott syndrome 0 trials
- Bleeding diathesis due to thromboxane synthesis deficiency 0 trials
- Bleeding disorder, platelet-type, 21 0 trials
- Bleeding disorder, platelet-type, 22 0 trials
- Bleeding disorder, platelet-type, 24 0 trials
- Bleeding disorder, platelet-type, 25 0 trials
- Cytosolic phospholipase-A2 alpha deficiency associated bleeding disorder 0 trials
- Gray platelet syndrome 0 trials
- Platelet-type bleeding disorder 11 0 trials
- Platelet-type bleeding disorder 12 0 trials
- Platelet-type bleeding disorder 14 0 trials
- Platelet-type bleeding disorder 15 0 trials
- Platelet-type bleeding disorder 16 0 trials
- Platelet-type bleeding disorder 17 0 trials
- Platelet-type bleeding disorder 18 0 trials
- Platelet-type bleeding disorder 19 0 trials
- Platelet-type bleeding disorder 20 0 trials
- Platelet-type bleeding disorder 8 0 trials
- Platelet-type bleeding disorder 9 0 trials
- Platelet-type von Willebrand disease 0 trials
- Primary release disorder of platelets 0 trials
-
Qualitative platelet defect 6 trials
-
TPM4-related platelet disorder 0 trials
Most studied deeper sub-types
-
New hope for myelofibrosis patients with dangerous low platelet counts
Disease control OngoingThis phase 3 study tests a drug called pacritinib against standard treatments chosen by the doctor in people with myelofibrosis who have very low platelet counts (below 50,000). The goal is to see if pacritinib can shrink the spleen and reduce symptoms like tiredness, pain, and i…
Phase 3 • Sponsor: Swedish Orphan Biovitrum • Aim: Disease control
Last updated Jun 27, 2026 12:26 UTC
-
Promising ITP drug trial pulled before it even started
Disease control CancelledThis study was designed to test the safety and tolerability of a new drug called HMPL-523 (sovleplenib) in adults with immune thrombocytopenia (ITP), a condition where the immune system destroys platelets, causing bleeding problems. The trial was withdrawn before enrolling any pa…
Phase 1 • Sponsor: Hutchmed • Aim: Disease control
Last updated Jun 26, 2026 18:23 UTC
-
Family history questions may improve bleeding disorder detection in kids
Knowledge-focused OngoingThis study looks at whether adding simple family history questions to a standard bleeding questionnaire can better identify children who truly have mild bleeding disorders. Researchers will review data from 1,000 children seen at a clinic since 2019. The goal is to see if this co…
Sponsor: Children's Hospital Medical Center, Cincinnati • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:25 UTC